· investment-strategies · 4 min read
Boston & Cambridge VC Firms 2026: Directory Shortlist for Biotech and Tech Founders
As of July 2026, the Boston–Cambridge funds we cover — General Catalyst, Battery, Third Rock, Atlas, CRV, F-Prime, Spark — plus when ARCH shows up on East Coast biotech caps.
Short answer (as of July 2026): For Boston–Cambridge fundraising, the firms we cover with full /fund/ profiles are General Catalyst (Cambridge HQ), Battery Ventures (Boston), Third Rock Ventures (Boston biotech creation), Atlas Venture (Cambridge biotech creation), CRV (Cambridge early-stage tech), F-Prime Capital (Cambridge life sciences / healthtech), and Spark Capital (NY + Boston). ARCH Venture Partners is Chicago-based — mention it when your biotech syndicate looks national, not as a local HQ shop.
This hub is a directory shortlist, not a market-size essay. For 2025–2026 Boston dollar flows and sector themes, read the Boston VC biotech dominance playbook. For companies mapped to this ecosystem, see Boston–Cambridge startups we cover. Browse all funds in the directory.
Firm table: stage, thesis, profile
| Firm | HQ (directory) | Stage signal (directory) | Thesis / when to pitch | Profile |
|---|---|---|---|---|
| General Catalyst | Cambridge, MA | Leads Series A / B+; invests seed → growth | Multi-stage AI, health, fintech, enterprise — full-stack platform, not biotech-only | /fund/general-catalyst |
| Battery Ventures | Boston, MA | Leads Series A / B+; invests seed → growth | Application software, infrastructure, consumer, industrial tech — Boston-founded since 1983 | /fund/battery-ventures |
| Third Rock Ventures | Boston, MA | Leads seed / Series A | Company-creation therapeutics — partners co-found with scientists | /fund/third-rock-ventures |
| Atlas Venture | Cambridge, MA | Leads seed / Series A | Early biotech creation from formation through Series A | /fund/atlas-venture |
| CRV | Cambridge, MA | Leads pre-seed / seed / Series A | Early software and tech (DoorDash seed history; Mercury / Vercel-class A’s) | /fund/crv |
| F-Prime Capital | Cambridge, MA | Leads Series A / B+; invests from seed | Life sciences, healthtech, plus selective enterprise / frontier — Fidelity-affiliated | /fund/f-prime-capital |
| Spark Capital | New York, NY & Boston, MA | Leads Series A / B+; invests seed → growth | Consumer + enterprise (Twitter, Slack, Discord, Coinbase vintage) — dual-city access | /fund/spark-capital |
| ARCH Venture Partners (optional) | Chicago, IL | Leads seed / Series A; invests through B+ | Deep-science biotech co-creation — relevant on Boston caps, not a Cambridge HQ | /fund/arch-venture-partners |
We do not invent AUM, DPI, IRR, or firm check sizes here. Where a fund’s JSON lists aum: N/A or omits a ticket, treat check size as undisclosed and ask the partner.
How founders should use this list
- Pick the process type. Third Rock and Atlas often build companies; CRV, Battery, Spark, and General Catalyst more often join a classic raise. Do not send the same deck narrative to both models.
- Match sector honestly. Therapeutics and platform biology → Third Rock, Atlas, F-Prime (± ARCH). Enterprise / infra / industrial → Battery, CRV, Spark, GC. Health + applied AI can sit in GC or F-Prime depending on clinical vs. software risk.
- Use Spark as NY+Boston, not “Boston-only.” If your buyers and talent are East Coast software, Spark is in-scope; if you need Kendall Square wet-lab company creation, prioritize Atlas / Third Rock.
- Cross-check portfolio reality. After shortlisting funds, open startups we cover in Boston–Cambridge and the Boston Metal industrial climate note for a hard-tech example outside pure biotech.
- Stay honest about coverage gaps. Flagship, RA Capital, Underscore, Pillar, and others appear in the biotech playbook editorial list but do not all have
/fund/pages here — do not treat this table as the full Boston phone book.
Biotech vs. tech split (practical)
| If you are raising for… | First calls from this directory | Secondary / national |
|---|---|---|
| Seed–A therapeutics creation | Third Rock, Atlas, F-Prime | ARCH (Chicago), later GC if platform becomes multi-stage |
| Seed–A enterprise / SaaS / infra | CRV, Battery, Spark, General Catalyst | Multi-stage Bay Area firms outside this hub |
| Healthtech / digital care (software-led) | General Catalyst, F-Prime, Spark | Battery when GTM looks enterprise |
| Industrial / climate hard tech | Battery, General Catalyst | Specialist climate LPs (not all on this list) |
What this page is not
- Not a 2025 fundraising totals report — that lives in the Boston biotech dominance playbook.
- Not an AUM ranking — we refuse fake precision when directory AUM is
N/A. - Not every Kendall Square seed fund — only firms in our whitelist with live fund JSON.
Next steps
- Company map: Boston–Cambridge startups we cover (2026)
- Market context: Boston VC biotech dominance playbook
- Hard-tech case: Boston Metal $75M
- Full fund browser: /directory
- East Coast frame: East Coast venture capital firms 2026
Sources
- Venture Capital Tracker fund profiles: /fund/general-catalyst, /fund/battery-ventures, /fund/third-rock-ventures, /fund/atlas-venture, /fund/crv, /fund/f-prime-capital, /fund/spark-capital, /fund/arch-venture-partners
- Boston VC in 2026 biotech dominance playbook (ecosystem dollars / themes)
- Firm public sites linked from directory JSON (
generalcatalyst.com,battery.com,thirdrockventures.com,atlasventure.com,crv.com,fprimecapital.com,sparkcapital.com,archventure.com)
- boston
- cambridge
- venture-capital
- +2 more